CClinicalTrials.gg
CompletedNCT00523016APSCIUpdated May 22, 2013

Acupuncture Treatment to Reduce Burning Pain in Spinal Cord Injury

An interventional study of Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP) and Sham acupuncture in Neuropathic Pain, sponsored by Toronto Rehabilitation Institute. Completed at 3 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-05-22.

Sponsored by Toronto Rehabilitation Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Acupuncture has been used with good results for many years at Toronto Rehabilitation Institute Lyndhurst Centre (Toronto, ON, Canada), Parkwood Hospital (London, ON, Canada) and GF Strong Rehabilitation Institute (Vancouver, BC, Canada) to reduce burning pain in individuals with spinal cord injuries (SCI). This multi-centre RCT will test an acupuncture protocol for treatment of burning pain in 40 people with burning pain in SCI, using a sham acupuncture protocol as the control.

Objectives of Study:

  1. To determine the feasibility of conducting a real acupuncture vs. sham acupuncture trial in a multi-centre study using the Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP). This will inform a larger study which will directly evaluate the effect of the LCCNPAP on pain and Quality of Life (QOL) in individuals with SCI.
  2. To determine which outcome measures are most responsive and the amount of change that could be expected, with respect to pain and QOL, for the larger study.
  3. To obtain preliminary data to determine subject numbers for future studies evaluating the effect of the acupuncture protocol.
Read the detailed description

40 individuals with SCI below-level neuropathic pain who are at least 6 weeks post-injury will be recruited at the three study sites. Subjects will be randomized into either the experimental or control group using a random number table as they enter the study to determine whether they will undergo the real acupuncture treatment or sham treatment.

A total of 13 treatments will be administered over a maximum of 4 consecutive weeks with an ideal treatment frequency as follows: 5 times per week during weeks one and two; and 3 times per week during week three.

Following all sessions, whether LCCNPAP group or sham, any adverse events such as nausea, fainting, bleeding etc., will be recorded on an adverse effects sheet for each subject. Baseline arterial blood pressure and heart rate will be monitored at four points during each treatment session for both groups.

02

Conditions studied

  • Neuropathic Pain

Keywords

  • acupuncture
  • electroacupuncture
  • sham acupuncture
  • spinal cord injury
  • neuropathic pain
  • burning pain
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 33 is above the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Toronto Rehabilitation Institute is the lead sponsor of 39 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • inpatients or outpatients
  • over 18 years of age
  • traumatic Spinal Cord Injury* (SCI) onset as an adult. *Traumatic SCI for the purposes of this study, is defined as: 'SCI due to sudden forceful impact on the spinal cord with or without bony injury'.This would include: falls, MVAs, hyperextension injuries, penetrating wounds (gunshot, knives), sports injuries, and exclude: tumours, vascular accidents (AVM), demyelinating conditions, infection, and iatrogenic causes.
  • major symptom of burning pain below SCI level
  • screened as positive for Central Neuropathic Pain by clinical assessment by Site Investigators which includes completing the LANSS Questionnaire
  • English-speaking
  • capable of giving informed consent
  • on stable pain therapy (i.e. no changes in pain medications for 1 week)

Exclusion criteria

Exclusion Criteria:

  • systemic illness
  • major psychiatric disorders
  • scalp lacerations or infections
  • hearing or language problems
  • history of diabetes or disease that would affect peripheral nerve function
  • pregnancy
  • serious co-morbidities
  • needle phobia
  • having undergone Lyndhurst Centre Central Neuropathic Pain Acupuncture Protocol previously
  • having had acupuncture in the last 30 days
  • treatment involving use of electrical therapy modalities (i.e. Codetron or TENS) in the last 30 days
  • seizure disorders, convulsions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Electroacupuncture

    Subjects will receive Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP) electroacupuncture protocol for 20 minutes per treatment session; a total of 13 treatments will be administered over 3-4 weeks.

    Procedure: Lyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP)

  • Sham comparator
    Sham acupuncture

    Subjects will receive simulated acupuncture that includes insertion of acupuncture needles on the head. During each treatment session, needles will be stimulated with electricity for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks. This group will be offered the LCCNPAP treatment at the completion of study participation.

    Procedure: Sham acupuncture

Interventions

  • ProcedureLyndhurst Central Neuropathic Pain Acupuncture Protocol (LCCNPAP)

    LCCNPAP: acupuncture needle insertion at acupuncture points on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks.

    Also known as: Electroacupuncture, Acupuncture + Electrical Stimulation

  • ProcedureSham acupuncture

    Sham acupuncture: Simulated acupuncture that includes insertion of acupuncture needles on the head that will be stimulated with electricity from a battery-operated Chinese acupuncture stimulation device for 20 minutes. A total of 13 treatments will be administered over 3-4 weeks. This group will be offered the LCCNPAP treatment at the completion of study participation.

    Also known as: Placebo acupuncture

06

What researchers measure

Primary outcomes

  1. Improvement in burning pain

    Time frame: Baseline, daily and weekly during treatment, end of study plus 1 month follow up

Secondary outcomes

  1. Improvement in Quality of Life measurements

    Time frame: Baseline, end of study plus 1 month follow-up

07

Study locations

3 sites
  • G. F. Strong Rehabilitation Centre
    Vancouver, British Columbia V5Z 2G9, Canada
  • Parkwood Hospital
    London, Ontario N6C 5J1, Canada
  • Toronto Rehabilitation Institute Lyndhurst Centre
    Toronto, Ontario M4G 3V9, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00523016
Lead sponsor
Toronto Rehabilitation Institute
Collaborators
Canadian Institutes of Health Research (CIHR), University of British Columbia
Responsible party
Linda M. Rapson (Adjunct Scientist, Toronto Rehabilitation Institute) — Principal investigator
First posted
Aug 30, 2007
Start date
Sep 2007
Primary completion
Apr 2013
Completion
May 2013
Last update
May 22, 2013

Study contacts

Linda M Rapson, MD
principal investigator · Toronto Rehabilitation Institute Lyndhurst Centre
Eva Widerström-Noga, PhD
study director · University of Miami
Judith Hunter, PhD
study director · University of Toronto
Judi Laprade, PhD
study director · University of Toronto
John Clement, MD
study director · Parkwood Hospital
Patrick Potter, MD
study director · Western University, Canada
Nimmi Bharatwal, MD
study director · University of Toronto
Andrei Krassioukov, MD
study director · University of British Columbia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion